KAPIOLANI MED CTR FOR WOMEN & CHILDR
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1M
- Transactions
- 137
- Companies
- 14
- Average per transaction
- $7,574
Who reported the payments
| Jazz Pharmaceuticals Inc. | $603,540 |
| Seagen Inc. | $328,096 |
| Merck | $34,477 |
| Pfizer | $30,981 |
| Incyte Corporation | $12,317 |
| Carl Zeiss Meditec, Inc. | $8,478 |
| Advanced Respiratory, Inc | $6,584 |
| National Marrow Donor Program | $6,250 |
| Med-el Corporation | $4,500 |
| E.r. Squibb & Sons, L.L.C. | $1,000 |
| Organon | $700 |
| Masimo Corporation | $315 |
| Stryker | $247 |
| KCI USA, Inc. | $150 |